N-(Azido-PEG4)-biocytin
Code | Size | Price |
---|
TAR-T16194-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T16194-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
N-(Azido-PEG4)-biocytin serves as a PEG-based PROTAC linker for PROTAC synthesis[1].
CAS:
2055042-70-9
Formula:
C27H47N7O9S
Molecular Weight:
645.77
Purity:
0.98
SMILES:
C(CCCC(NCCCC[C@H](NC(CCOCCOCCOCCOCCN=[N+]=[N-])=O)C(O)=O)=O)[C@H]1[C@@]2([C@](CS1)(NC(=O)N2)[H])[H]
References
An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562